Salt, water and nephron: Mechanisms of action and link to hypertension and chronic kidney disease
Q Qian - Nephrology, 2018 - Wiley Online Library
Our knowledge on sodium and water homeostasis and regulation continues to evolve. A
considerable amount of new information in this area has emerged in recent years. This …
considerable amount of new information in this area has emerged in recent years. This …
[HTML][HTML] Vasopressin–aquaporin-2 pathway: recent advances in understanding water balance disorders
The alteration of water balance and related disorders has emerged as being strictly linked to
the state of activation of the vasopressin–aquaporin-2 (vasopressin–AQP2) pathway. The …
the state of activation of the vasopressin–aquaporin-2 (vasopressin–AQP2) pathway. The …
Metabolomic analysis of urine samples by UHPLC-QTOF-MS: Impact of normalization strategies
Y Gagnebin, D Tonoli, P Lescuyer, B Ponte… - Analytica chimica …, 2017 - Elsevier
Among the various biological matrices used in metabolomics, urine is a biofluid of major
interest because of its non-invasive collection and its availability in large quantities …
interest because of its non-invasive collection and its availability in large quantities …
Associations of urinary uromodulin with clinical characteristics and markers of tubular function in the general population
M Pruijm, B Ponte, D Ackermann… - Clinical journal of the …, 2016 - journals.lww.com
Results In both studies, positive associations were found between uromodulin and urinary
sodium, chloride, and potassium excretion and osmolality. In SKIPOGH, 24-hour uromodulin …
sodium, chloride, and potassium excretion and osmolality. In SKIPOGH, 24-hour uromodulin …
Urine osmolality, response to tolvaptan, and outcome in autosomal dominant polycystic kidney disease: results from the TEMPO 3: 4 trial
O Devuyst, AB Chapman, RT Gansevoort… - Journal of the …, 2017 - journals.lww.com
The vasopressin–cAMP–osmolality axis is abnormal in autosomal dominant polycystic
kidney disease (ADPKD). In the Tolvaptan Efficacy and Safety in Management of Autosomal …
kidney disease (ADPKD). In the Tolvaptan Efficacy and Safety in Management of Autosomal …
[HTML][HTML] Plasma copeptin levels predict disease progression and tolvaptan efficacy in autosomal dominant polycystic kidney disease
RT Gansevoort, MDA van Gastel, AB Chapman… - Kidney international, 2019 - Elsevier
In the TEMPO 3: 4 Trial, treatment with tolvaptan, a vasopressin V2 receptor antagonist,
slowed the increase in total kidney volume and decline in estimated glomerular filtration rate …
slowed the increase in total kidney volume and decline in estimated glomerular filtration rate …
Effect of increased water intake on plasma copeptin in healthy adults
G Lemetais, O Melander, M Vecchio, JH Bottin… - European journal of …, 2018 - Springer
Purpose Inter-individual variation in median plasma copeptin is associated with incident
type 2 diabetes mellitus, progression of chronic kidney disease, and cardiovascular events …
type 2 diabetes mellitus, progression of chronic kidney disease, and cardiovascular events …
Plasma copeptin, kidney outcomes, ischemic heart disease, and all-cause mortality in people with long-standing type 1 diabetes
G Velho, R El Boustany, G Lefèvre… - Diabetes …, 2016 - Am Diabetes Assoc
OBJECTIVE Plasma copeptin, a surrogate for vasopressin, has been associated with a
decline in renal function and albuminuria in population-based studies as well as with …
decline in renal function and albuminuria in population-based studies as well as with …
Antidiuretic hormone and serum osmolarity physiology and related outcomes: what is old, what is new, and what is unknown?
Context Although the physiology of sodium, water, and arginine vasopressin (AVP), also
known as antidiuretic hormone, has long been known, accumulating data suggest that this …
known as antidiuretic hormone, has long been known, accumulating data suggest that this …
Renocardiovascular biomarkers: from the perspective of managing chronic kidney disease and cardiovascular disease
S Niizuma, Y Iwanaga, T Yahata… - Frontiers in cardiovascular …, 2017 - frontiersin.org
Mortality among the patients with chronic kidney disease (CKD) and end-stage renal
disease (ESRD) remains high because of the very high incidence of cardiovascular disease …
disease (ESRD) remains high because of the very high incidence of cardiovascular disease …